NASDAQ:LHCG - LHC Group Stock Price, Forecast & News

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) announced its quarterly earnings data on Wednesday, November, 6th. The health services provider reported $1.26 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.08 by $0.18. The health services provider had revenue of $528.50 million for the quarter, compared to analyst estimates of $534.15 million. LHC Group had a net margin of 4.59% and a return on equity of 9.39%. The company's revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.95 EPS. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for LHC Group.

LHC Group will be holding an earnings conference call on Wednesday, February 26th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

11 brokers have issued twelve-month price objectives for LHC Group's stock. Their forecasts range from $114.00 to $160.00. On average, they expect LHC Group's stock price to reach $133.80 in the next year. This suggests that the stock has a possible downside of 13.7%. View Analyst Price Targets for LHC Group.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

Press coverage about LHCG stock has trended very positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. LHC Group earned a news impact score of 3.1 on InfoTrie's scale. They also gave press coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for LHC Group.

LHC Group saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,850,000 shares, an increase of 9.5% from the January 15th total of 1,690,000 shares. Based on an average trading volume of 200,700 shares, the short-interest ratio is currently 9.2 days. Currently, 6.2% of the shares of the stock are short sold. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), BioScrip (BIOS), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), Home Depot (HD), Cisco Systems (CSCO), Alibaba Group (BABA), CVS Health (CVS), Visa (V), Chevron (CVX), NVIDIA (NVDA), Walt Disney (DIS) and AT&T (T).

LHC Group's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include FMR LLC (5.29%), State Street Corp (2.77%), Alliancebernstein L.P. (2.13%), Victory Capital Management Inc. (2.12%), Victory Capital Management Inc. (2.10%) and Bank of New York Mellon Corp (1.91%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Redwood Investments LLC, Rothschild & Co. Asset Management US Inc., Man Group plc, Robeco Institutional Asset Management B.V., Principal Financial Group Inc., Sei Investments Co., Arizona State Retirement System and Loomis Sayles & Co. L P. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, John L Indest, Joshua L Proffitt, Keith G Myers and Ronald T Nixon. View Insider Buying and Selling for LHC Group.

LHCG stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Magnetar Financial LLC, Sumitomo Mitsui Trust Holdings Inc., Janus Henderson Group PLC, Westwood Management Corp IL, Columbus Circle Investors, Bank of New York Mellon Corp and Victory Capital Management Inc.. View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $155.00.

LHC Group has a market capitalization of $4.88 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]